Down-Regulation of Oncogene c-myb Specifically by Carbazole Derivative Through Opposing Effects on Different Quadruplex Structures of Gene Promoter for Cancer Treatment
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178299 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Siyi Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou University City, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Carbazoles, Promoter Regions, Genetic, G-Quadruplexes, Proto-Oncogene Proteins c-myb. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Cancer is one of the leading causes of human mortality worldwide, and aberrant expression of the c-myb oncogene is closely associated with the development of numerous malignancies. The c-myb promoter region contains G-rich and C-rich sequences capable of forming G-quadruplex (G4) and i-motif (IM or C-quadruplex) structures, respectively. These secondary structures function as “molecular switches” for gene transcriptional regulation and represent promising targets for novel anti-tumor therapeutics. Through extensive screening, we identified carbazole derivative G51 as a unique dual-targeting ligand that simultaneously destabilized the i-motif and stabilized the G-quadruplex, consequently suppressing c-myb expression efficiently. In comparison, the single-targeting ligand G50, which could specifically bind to and unfold the G-quadruplex only, exhibited significantly weaker anti-tumor activity than G51. Notably, G51 showed potent anti-tumor efficacy in a human colorectal cancer xenograft model without significant toxicity to vital organs. G51, as a dual-targeting ligand, had specific binding to c-myb promoter quadruplexes, with destabilization of the i-motif and concurrent stabilization of the G-quadruplex. This opposing effect could provide a good opportunity for specific gene regulation, with great potential for further development of a precise therapeutic agent. This study provides a novel example for a practical therapeutic approach through coordinated gene quadruplex modulations, which sets up a good foundation for developing high-efficacy anti-tumor drugs without significant side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou University City, Guangzhou 510006, China.
ORCID-Profile: Ding Li
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Wang, S., Liang, J., Zhang, J., Ji, D., Huang, Z. S., & Li, D. (2025). Down-Regulation of Oncogene c-myb Specifically by Carbazole Derivative Through Opposing Effects on Different Quadruplex Structures of Gene Promoter for Cancer Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178299
Vancouver
Wang S, Liang J, Zhang J, Ji D, Huang ZS, Li D. Down-Regulation of Oncogene c-myb Specifically by Carbazole Derivative Through Opposing Effects on Different Quadruplex Structures of Gene Promoter for Cancer Treatment. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178299
BibTeX
@article{Wang2025,
author = {Wang, Siyi and Liang, Jihai and Zhang, Jiahui and Ji, Dongsheng and Huang, Zhi-Shu and Li, Ding},
title = {Down-Regulation of Oncogene c-myb Specifically by Carbazole Derivative Through Opposing Effects on Different Quadruplex Structures of Gene Promoter for Cancer Treatment},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178299}
}
EUVIMED